| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 775.30B | 652.99B | 614.49B | 562.56B | 491.73B |
| Gross Profit | 297.80B | 258.10B | 226.19B | 197.82B | 156.17B |
| EBITDA | 196.64B | 180.14B | 145.40B | 127.26B | 104.22B |
| Net Income | 119.70B | 92.63B | 82.65B | 66.29B | 60.20B |
Balance Sheet | |||||
| Total Assets | 1.23T | 990.97B | 975.72B | 903.10B | 823.18B |
| Cash, Cash Equivalents and Short-Term Investments | 188.56B | 233.46B | 207.92B | 219.79B | 188.34B |
| Total Debt | 243.51B | 156.68B | 178.11B | 186.42B | 154.74B |
| Total Liabilities | 451.79B | 316.24B | 337.42B | 339.36B | 305.19B |
| Stockholders Equity | 770.75B | 674.57B | 637.68B | 563.67B | 514.32B |
Cash Flow | |||||
| Free Cash Flow | 77.00B | 98.14B | 82.72B | 44.98B | 44.07B |
| Operating Cash Flow | 115.98B | 132.92B | 118.18B | 69.31B | 71.91B |
| Investing Cash Flow | -175.51B | -34.25B | -92.16B | -37.38B | 10.23B |
| Financing Cash Flow | 30.34B | -71.00B | -57.45B | -1.77B | -53.83B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $12.31B | 11.32 | 15.50% | 2.71% | 13.16% | 23.72% | |
74 Outperform | $12.68B | 11.51 | 6.34% | 1.24% | 2.36% | 34.03% | |
74 Outperform | $6.53B | 8.78 | 10.41% | 2.63% | 2.86% | 17.30% | |
64 Neutral | $9.46B | 21.96 | 29.49% | 1.07% | 13.99% | -25.70% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
57 Neutral | $6.32B | 23.74 | 7.93% | 4.00% | -1.37% | -24.48% | |
53 Neutral | $3.60B | -8.89 | -12.67% | 1.70% | -23.37% | -131.29% |